Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Ann Am Thorac Soc 2017 May
Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.
Related Questions
Does your approach to treating latent tuberculosis differ in a patient on anti-fibrotic therapy?
New comment
by at Geisinger Healthplex State College PA ( June 30, 2023)
Simple Answer: No. Nevertheless, increased vigilance is warranted due to the Higher risk profile in such patients for reactivation.
Read more (1 Answer available)
16705
×
To continue please login or register
Register
or
Sign in